MedTrace Logo

Availability and Advice on Test Uptake During the COVID-19 Pandemic: a Vignette Study.

NCT05215483 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3270

Last updated 2022-01-31

No results posted yet for this study

Summary

Lateral Flow Testing (LFT) use for COVID-19 related symptoms continues to rise, despite governmental advice to test at a test facility. In this study we investigate whether 1) adjusting the governmental testing advice will lead to a collective increase of people who test with COVID-19 symptoms and if this leads to a higher strategy sensitivity.

Conditions

Interventions

BEHAVIORAL

Customised testing advice

Customised advice: With Corona related symptoms, get tested at a test facility. If this isn't possible, use a Lateral Flow test.

BEHAVIORAL

Regular testing advice

Government guideline testing advice: "With Corona related symptoms, get tested at a test facility".

BEHAVIORAL

LFT available

LFT availability: Enough lateral flow tests available at home

BEHAVIORAL

No LFT available

LFT availability: No lateral flow tests available at home

Sponsors & Collaborators

  • National Institute for Public Health and the Environment (RIVM)

    lead OTHER_GOV

Principal Investigators

  • Marijn de Bruin, prof · RIVM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-11
Primary Completion
2021-11-16
Completion
2021-11-16

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05215483 on ClinicalTrials.gov